tadalafil has been researched along with Diabetes Mellitus in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (58.33) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| El-Nashaar, AM; Mostafa, T; Osman, IA; Said, SZ; Zaghloul, AS | 1 |
| Abdel-Aal, FAM; Ali, ABH; Mohamed, AI; Rageh, AH | 1 |
| Calogero, AE; Condorelli, RA; Favilla, V; La Vignera, S; Lotti, F; Maggi, M; Morgia, G; Vicari, E | 1 |
| Banerjee, SK; Katare, PB | 1 |
| Corona, G; Fusco, F; Mondaini, N; Razzoli, E; Rossi, A; Ungar, A | 1 |
| Salama, N | 1 |
| Denne, J; Fonseca, V; Fredlund, P; Seftel, A | 1 |
| Buvat, J; Chan, M; Kuepfer, C; Schmitt, H; van Ahlen, H; Varanese, L | 1 |
| Chan, M; Costigan, TM; Hutter, AM; Jackson, G; Kloner, RA; Mittleman, MA; Vail, GM; Warner, MR | 1 |
| Bedding, AW; Forgue, ST; Jewell, H; Mitchell, MI; Patterson, BE; Payne, CD; Phillips, DL; Wrishko, RE | 1 |
| Ahuja, S; Goldstein, I; Kim, E; Natanegara, F; Pryor, JL; Steers, WD; Wilde, DW; Wong, DG | 1 |
| Liu, ZY; Sun, YH | 1 |
4 review(s) available for tadalafil and Diabetes Mellitus
| Article | Year |
|---|---|
Repositioning of Drugs in Cardiometabolic Disorders: Importance and Current Scenario.
Topics: Allopurinol; Aspirin; Bromocriptine; Cardiovascular Diseases; Clonidine; Colesevelam Hydrochloride; Diabetes Mellitus; Drug Discovery; Drug Evaluation, Preclinical; Drug Repositioning; Humans; Metabolic Syndrome; Piperazines; Tadalafil | 2016 |
Phosphodiesterase type 5 (PDE5) inhibitors in erectile dysfunction: the proper drug for the proper patient.
Topics: Algorithms; Carbolines; Cardiovascular Diseases; Diabetes Mellitus; Humans; Hypertension; Imidazoles; Impotence, Vasculogenic; Male; Men's Health; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Pyrimidines; Risk Factors; Sildenafil Citrate; Sulfonamides; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride | 2011 |
Cardiovascular safety update of Tadalafil: retrospective analysis of data from placebo-controlled and open-label clinical trials of Tadalafil with as needed, three times-per-week or once-a-day dosing.
Topics: Aged; Carbolines; Clinical Trials as Topic; Comorbidity; Coronary Artery Disease; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Administration Schedule; Erectile Dysfunction; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Myocardial Infarction; Phosphodiesterase Inhibitors; Retrospective Studies; Tadalafil | 2006 |
[Evaluation of tadalafil for the treatment of erectile dysfunction].
Topics: Carbolines; Diabetes Mellitus; Erectile Dysfunction; Humans; Hypertension; Male; Phosphodiesterase Inhibitors; Tadalafil; Treatment Outcome | 2008 |
4 trial(s) available for tadalafil and Diabetes Mellitus
| Article | Year |
|---|---|
Nocturnal electrobioimpedance volumetric assessment in diabetic men with erectile dysfunction before and after tadalafil intake.
Topics: Arterial Occlusive Diseases; Blood Volume; Carbolines; Diabetes Mellitus; Electric Impedance; Erectile Dysfunction; Humans; Male; Middle Aged; Tadalafil | 2004 |
Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data from tadalafil clinical trials.
Topics: Blood Glucose; Carbolines; Diabetes Mellitus; Double-Blind Method; Erectile Dysfunction; Glycated Hemoglobin; Humans; Male; Middle Aged; Penile Erection; Phosphodiesterase Inhibitors; Placebos; Tadalafil | 2004 |
Efficacy and safety of two dosing regimens of tadalafil and patterns of sexual activity in men with diabetes mellitus and erectile dysfunction: Scheduled use vs. on-demand regimen evaluation (SURE) study in 14 European countries.
Topics: Adult; Aged; Carbolines; Comorbidity; Cross-Over Studies; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Administration Schedule; Erectile Dysfunction; Europe; Humans; Male; Middle Aged; Patient Satisfaction; Penile Erection; Phosphodiesterase Inhibitors; Sexual Behavior; Surveys and Questionnaires; Tadalafil; Treatment Outcome; Vasodilator Agents | 2006 |
Efficacy and safety of tadalafil in men with erectile dysfunction with a high prevalence of comorbid conditions: results from MOMENTUS: multiple observations in men with erectile dysfunction in National Tadalafil Study in the US.
Topics: Age Distribution; Aged; Carbolines; Comorbidity; Depression; Diabetes Mellitus; Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Hypertension; Male; Middle Aged; Penile Erection; Phosphodiesterase Inhibitors; Prevalence; Tadalafil; Treatment Outcome; United States | 2007 |
4 other study(ies) available for tadalafil and Diabetes Mellitus
| Article | Year |
|---|---|
Assessment of the intracavernosal injection platelet-rich plasma in addition to daily oral tadalafil intake in diabetic patients with erectile dysfunction non-responding to on-demand oral PDE5 inhibitors.
Topics: Carbolines; Diabetes Mellitus; Erectile Dysfunction; Humans; Male; Penile Erection; Phosphodiesterase 5 Inhibitors; Piperazines; Platelet-Rich Plasma; Sulfones; Tadalafil; Treatment Outcome | 2022 |
Cytochrome P450 3A4-mediated pharmacokinetic interaction study between tadalafil and canagliflozin using high-performance thin-layer chromatography.
Topics: Canagliflozin; Chromatography, Thin Layer; Cytochrome P-450 Enzyme System; Diabetes Mellitus; Erectile Dysfunction; Humans; Male; Tadalafil | 2022 |
Seminal vesicles and diabetic neuropathy: ultrasound evaluation after prolonged treatment with a selective phosphodiesterase-5 inhibitor.
Topics: Adult; Carbolines; Diabetes Mellitus; Diabetic Neuropathies; Ejaculation; Erectile Dysfunction; Humans; Infertility, Male; Male; Phosphodiesterase 5 Inhibitors; Semen Analysis; Seminal Vesicles; Sperm Count; Sperm Motility; Tadalafil; Ultrasonography | 2013 |
Effects of gender, age, diabetes mellitus and renal and hepatic impairment on tadalafil pharmacokinetics.
Topics: Adult; Age Factors; Belgium; Carbolines; Diabetes Mellitus; Erectile Dysfunction; Female; Germany; Humans; Kidney Diseases; Liver Diseases; Male; Middle Aged; Phosphodiesterase Inhibitors; Poland; Sex Factors; Tadalafil; United Kingdom | 2007 |